https://nova.newcastle.edu.au/vital/access/ /manager/Index ${session.getAttribute("locale")} 5 https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:36299 Wed 27 Apr 2022 14:49:19 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:16262 Wed 11 Apr 2018 17:19:09 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:28306 70%, five students scored between 57%–69%, one student obtained a mark of 50% and one student failed. The end of course survey revealed that while students found portfolio development challenging (40%), they also reported that it was effective for self-learning (54%). Differentiating between the concepts “reflection” and “evaluation” in CPD was problematic for some students and the use of clearer, simpler language should be used to explain these processes in future CPD work.]]> Wed 11 Apr 2018 17:05:02 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:18251 Wed 11 Apr 2018 15:42:47 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:30826 Wed 11 Apr 2018 13:13:06 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:13459 Wed 11 Apr 2018 12:33:52 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:19750 Wed 11 Apr 2018 11:51:07 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:41685 Wed 10 Aug 2022 15:08:18 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:29807 Wed 09 Feb 2022 15:58:30 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:50376 Wed 01 May 2024 14:50:59 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:46742 Tue 29 Nov 2022 15:25:53 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:36298 Tue 24 Mar 2020 16:44:30 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:49592 Tue 23 May 2023 11:55:57 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:41786 Tue 23 Jan 2024 16:08:35 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:40847 Tue 19 Jul 2022 11:15:21 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:39120 n = 4) while no reason was given in four studies. Seven studies reported that through screening, pharmacists could identify adults with undiagnosed depression. Pharmacists referred adults screening positive for assessment in seven studies and followed up participants in two studies. No study assessed the impact of screening on depressive symptoms or the cost-effectiveness of pharmacists screening for depression. Conclusion: Community pharmacists are able to use depression screening tools to identify undiagnosed adults having symptoms of depression. However, there is little evidence around the impact of this screening on clinical and economic outcomes. Larger, well-designed studies that use a highly accurate, easily administered screening tool and include patient referral and follow-up and pharmacist training are warranted to provide evidence on the impact of community pharmacists screening adults for depression.]]> Tue 10 May 2022 17:14:36 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:51187 Tue 09 Jan 2024 11:21:55 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:37418 Thu 12 Nov 2020 17:45:51 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:37016 Thu 09 Dec 2021 11:04:18 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:52234 Thu 05 Oct 2023 11:39:44 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:21866 Sat 24 Mar 2018 07:59:11 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:26335 Sat 24 Mar 2018 07:35:57 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:29671 –1 provided a stable model and lowest objective function. This represents extremely rapid absorption with a half-life of 5 min. The final model had a clearance of 41.9 l h^–1 and volume of distribution of the central compartment of, 73.6 l. Median and interquartile range of initial (alpha) half-life was 0.32 h (0.26–0.37 h) and second (beta) half-life was 3.0 h (2.5–3.6 h). Simulations indicate that 10 mg alone provides an 80% probability of being above the lower limit of quantification (5 μg l^–1) for 7 h, 2 h longer than for 5 mg. Giving two 10 mg doses increased this duration to 10 h. Conclusions: Intramuscular droperidol is rapidly absorbed with high therapeutic concentrations after 5 and 10 mg doses, and supports clinical data in which droperidol sedates rapidly for up to 6 h.]]> Sat 24 Mar 2018 07:32:21 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:38260 9-tetrahydrocannabinol (∆⁹-THC). Evidence is emerging for the therapeutic benefits of cannabis in the treatment of neurological and neurodegenerative diseases, with potential efficacy as an analgesic and antiemetic for the management of cancer-related pain and treatment-related nausea and vomiting, respectively. An increasing number of preclinical studies have established that ∆⁹-THC can inhibit the growth and proliferation of cancerous cells through the modulation of cannabinoid receptors (CB1R and CB2R), but clinical confirmation remains lacking. In parallel, the anti-cancer properties of non-THC cannabinoids, such as cannabidiol (CBD), are linked to the modulation of non-CB1R/CB2R G-protein-coupled receptors, neurotransmitter receptors, and ligand-regulated transcription factors, which together modulate oncogenic signalling and redox homeostasis. Additional evidence has also demonstrated the anti-inflammatory properties of cannabinoids, and this may prove relevant in the context of peritumoural oedema and the tumour immune microenvironment. This review aims to document the emerging mechanisms of anti-cancer actions of non-THC cannabinoids.]]> Mon 29 Jan 2024 17:45:13 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:32044 Mon 23 Sep 2019 12:07:25 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:40390 p < 0.0001, and that students found using AR was stimulating, interactive, engaging and easy to follow. Thus, AR technology could be an effective way to enhance student learning about medicines.]]> Mon 11 Jul 2022 11:21:37 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:51387 Mon 04 Sep 2023 13:12:11 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:47211 P < .001). Conclusions: This study describes a valid and rigorous approach for the implementation and interpretation of an integrated simulation-based assessment tool for determining pharmacy student's progress towards entrustment for independent medication supply practice.]]> Fri 12 May 2023 10:57:01 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:43007 Fri 09 Sep 2022 14:24:20 AEST ]]>